Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes

BACKGROUND & AIMS: Studies have described prominent histologic improvement in patients with nonalcoholic steatohepatitis (NASH) using thiazolidinedione (TZD); however, these were all short term with moderate sample size, no liver‐related long‐term outcomes could be noted. METHODS: This retrospec...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Liver Int
Egile Nagusiak: Yen, Fu‐Shun, Yang, Yu‐Cih, Hwu, Chii‐Min, Wei, James C.‐C., Huang, Yi‐Hsiang, Hou, Ming‐Chih, Hsu, Chih‐Cheng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Metabolic & Toxic Liver Diseases
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7317545/
https://ncbi.nlm.nih.gov/pubmed/31960563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14385
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak